Sign up to Receive the Quarterly Protein Update!
Webinar: GMP Raw Materials for Cell Therapy Manufacture: What, When and How?
Join Dr. Diane Wotta, Senior Director, Quality & Regulatory Affairs, R&D Systems, Inc., Dr. Sadik Kassim, Vice President, Process & Analytical Development, Mustang Bio, Inc, and John Tomtishen, Product Steward - Manufacturing Science & Technology, Cell & Gene Technical Development & Manufacturing, Novartis, as they discuss definitions, regulatory guidelines, and case studies. Watch Now
Enhancing Cell Therapies using Cellular Glycoengineering to Promote Homing
A recent Harvard study suggests that enhancing cell surface sLeX on naïve Treg cells using Fucosyltransferase 7, promotes Treg accumulation at inflammatory sites where they suppress xenogenic GVHD disease. Similar results have also been obtained for B cells and MSCs. It is suggested this novel technique might greatly decrease the required therapeutic dose and help mitigate off-target effects. Learn More
View ALL New Proteins
See more of our Quarterly Product and Data Updates:
Quarterly Protein Product and Data Update: Edition #3
Quarterly Protein Product and Data Update: Edition #2
Quarterly Protein Product and Data Update: Edition #1